HUP0302720A2 - Pirazolo[4,3d]pirimidin-származékok alkalmazása gyógyszerkészítmények előállítására - Google Patents
Pirazolo[4,3d]pirimidin-származékok alkalmazása gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP0302720A2 HUP0302720A2 HU0302720A HUP0302720A HUP0302720A2 HU P0302720 A2 HUP0302720 A2 HU P0302720A2 HU 0302720 A HU0302720 A HU 0302720A HU P0302720 A HUP0302720 A HU P0302720A HU P0302720 A2 HUP0302720 A2 HU P0302720A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- groups
- carbon atoms
- atom
- hydrogen atom
- Prior art date
Links
- APXRHPDHORGIEB-UHFFFAOYSA-N 1H-pyrazolo[4,3-d]pyrimidine Chemical class N1=CN=C2C=NNC2=C1 APXRHPDHORGIEB-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- -1 COOA Chemical group 0.000 abstract 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000018262 Peripheral vascular disease Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 201000009961 allergic asthma Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 208000023819 chronic asthma Diseases 0.000 abstract 1
- 230000007882 cirrhosis Effects 0.000 abstract 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 208000024798 heartburn Diseases 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 208000002815 pulmonary hypertension Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000012201 sexual and gender identity disease Diseases 0.000 abstract 1
- 208000015891 sexual disease Diseases 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány (I) általános képletű vegyületek, ahol R1 és R2 jelentéseegymástól függetlenül hidrogénatom, A, OH, OA csoport vagyhalogénatom, vagy R1 és R2 együtt 3-5 szénatomos alkilén-, -O-CH2-CH2-, -CH2-O-CH2-, -O-CH2-O- vagy -O-CH2-CH2-O- csoportot alkot, R3 ésR4 jelentése egymástól függetlenül hidrogénatom vagy A csoport, Xjelentése R5, R6 vagy R7 csoport, amelyek valamennyien R8-calszubsztituálva vannak, R5 jelentése egyenes vagy elágazó láncú 1-10szénatomos alkiléncsoport, amelyben egy vagy két CH2 csoport -CH=CH-csoporttal, oxigén-, kénatommal vagy SO csoporttal helyettesítvelehet, R6 jelentése 5-12 szénatomos cikloalkil- vagy cikloalkil-alkilén-csoport, R7 jelentése fenil- vagy fenilmetil-csoport, R8jelentése COOH, COOA, CONH2, CONHA, CON(A)2 vagy CN csoport, Ajelentése 1-6 szénatomos alkilcsoport, Hal jelentése fluor-, klór-,bróm- vagy jódatom, és fiziológiailag alkalmazható sóik és szolvátjaikalkalmazására vonatkozik angina, magas vérnyomás, pulmonálishipertenzió, szívszélhűdés, ateroszklerózis, a szív ereinekcsökkentett nyitottságával kapcsolatos állapotok, perifériásérmegbetegedések, gutaütés, bronchitis, allergiás asztma, krónikusasztma, allergiás nátha, glaukóma, irritálható bélszindróma, tumorok,veseelégtelenség, májcirrózis és női szexuális rendellenességekkezelésére alkalmas gyógyszer előállítására. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10058662A DE10058662A1 (de) | 2000-11-25 | 2000-11-25 | Verwendung von Pyrazolo[4,3-d]pyrimidinen |
| PCT/EP2001/012493 WO2002041880A2 (de) | 2000-11-25 | 2001-10-29 | Verwendung von pyrazolo[4,3-d]pyrimidinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0302720A2 true HUP0302720A2 (hu) | 2003-11-28 |
Family
ID=7664710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0302720A HUP0302720A2 (hu) | 2000-11-25 | 2001-10-29 | Pirazolo[4,3d]pirimidin-származékok alkalmazása gyógyszerkészítmények előállítására |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20040023990A1 (hu) |
| EP (1) | EP1357904A2 (hu) |
| JP (1) | JP2004513963A (hu) |
| KR (1) | KR20030051870A (hu) |
| CN (1) | CN1665508A (hu) |
| AR (1) | AR035373A1 (hu) |
| AU (1) | AU2002215979A1 (hu) |
| BR (1) | BR0115187A (hu) |
| CA (1) | CA2429645A1 (hu) |
| CZ (1) | CZ20031668A3 (hu) |
| DE (1) | DE10058662A1 (hu) |
| HU (1) | HUP0302720A2 (hu) |
| MX (1) | MXPA03004498A (hu) |
| PL (1) | PL363077A1 (hu) |
| RU (1) | RU2003117477A (hu) |
| SK (1) | SK7592003A3 (hu) |
| WO (1) | WO2002041880A2 (hu) |
| ZA (1) | ZA200304908B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19942474A1 (de) * | 1999-09-06 | 2001-03-15 | Merck Patent Gmbh | Pyrazolo[4,3-d]pyrimidine |
| SK8192003A3 (en) * | 2000-12-19 | 2003-10-07 | Merck Patent Gmbh | Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidines and antithrombotic agents, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| JP4015176B2 (ja) | 2003-04-29 | 2007-11-28 | ファイザー・インク | 高血圧症の治療に有用な５，７−ジアミノピラゾロ４，３−ジピリミジン類 |
| US7572799B2 (en) * | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| GB0327323D0 (en) * | 2003-11-24 | 2003-12-31 | Pfizer Ltd | Novel pharmaceuticals |
| DK1742950T3 (da) * | 2004-04-07 | 2009-03-16 | Pfizer Ltd | Pyrazolo-[4,3-D]-pyrimidiner |
| US11725395B2 (en) | 2009-09-04 | 2023-08-15 | Välinge Innovation AB | Resilient floor |
| US8365499B2 (en) | 2009-09-04 | 2013-02-05 | Valinge Innovation Ab | Resilient floor |
| RU2019112740A (ru) | 2016-09-30 | 2020-11-02 | АСАНА БАЙОСАЙЕНСИЗ, ЭлЭлСи | P2x3 и/или p2x2/3 соединения и способы |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2657760B2 (ja) * | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | ４−アミノキナゾリン誘導体およびそれを含有する医薬品 |
| GB9423911D0 (en) * | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
| US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
| DE19942474A1 (de) * | 1999-09-06 | 2001-03-15 | Merck Patent Gmbh | Pyrazolo[4,3-d]pyrimidine |
| DE10031584A1 (de) * | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine |
-
2000
- 2000-11-25 DE DE10058662A patent/DE10058662A1/de not_active Withdrawn
-
2001
- 2001-10-29 HU HU0302720A patent/HUP0302720A2/hu unknown
- 2001-10-29 RU RU2003117477/15A patent/RU2003117477A/ru not_active Application Discontinuation
- 2001-10-29 EP EP01997300A patent/EP1357904A2/de not_active Withdrawn
- 2001-10-29 WO PCT/EP2001/012493 patent/WO2002041880A2/de not_active Application Discontinuation
- 2001-10-29 PL PL01363077A patent/PL363077A1/xx unknown
- 2001-10-29 SK SK759-2003A patent/SK7592003A3/sk unknown
- 2001-10-29 KR KR10-2003-7006947A patent/KR20030051870A/ko not_active Application Discontinuation
- 2001-10-29 CZ CZ20031668A patent/CZ20031668A3/cs unknown
- 2001-10-29 CA CA002429645A patent/CA2429645A1/en not_active Abandoned
- 2001-10-29 AU AU2002215979A patent/AU2002215979A1/en not_active Abandoned
- 2001-10-29 CN CN018194281A patent/CN1665508A/zh active Pending
- 2001-10-29 MX MXPA03004498A patent/MXPA03004498A/es unknown
- 2001-10-29 US US10/432,772 patent/US20040023990A1/en not_active Abandoned
- 2001-10-29 JP JP2002544059A patent/JP2004513963A/ja active Pending
- 2001-10-29 BR BR0115187-8A patent/BR0115187A/pt not_active Application Discontinuation
- 2001-11-23 AR ARP010105461A patent/AR035373A1/es unknown
-
2003
- 2003-06-24 ZA ZA200304908A patent/ZA200304908B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK7592003A3 (en) | 2003-11-04 |
| AR035373A1 (es) | 2004-05-12 |
| MXPA03004498A (es) | 2003-09-05 |
| WO2002041880A3 (de) | 2003-08-28 |
| US20040023990A1 (en) | 2004-02-05 |
| CZ20031668A3 (cs) | 2003-10-15 |
| WO2002041880A2 (de) | 2002-05-30 |
| DE10058662A1 (de) | 2002-05-29 |
| BR0115187A (pt) | 2004-01-20 |
| PL363077A1 (en) | 2004-11-15 |
| CN1665508A (zh) | 2005-09-07 |
| CA2429645A1 (en) | 2002-05-30 |
| AU2002215979A1 (en) | 2002-06-03 |
| KR20030051870A (ko) | 2003-06-25 |
| EP1357904A2 (de) | 2003-11-05 |
| RU2003117477A (ru) | 2004-11-27 |
| JP2004513963A (ja) | 2004-05-13 |
| ZA200304908B (en) | 2004-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303315A2 (hu) | Pirazolo [4,3-d] pirimidineket és trombózisellenes szereket, kalcium antagonistákat, prosztaglandinokat vagy prosztaglandinszármazékokat tartalmazó gyógyszerkészítmények | |
| HUP0400818A2 (hu) | Tieno[2,3-d]pirimidinek alkalmazása és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP0302720A2 (hu) | Pirazolo[4,3d]pirimidin-származékok alkalmazása gyógyszerkészítmények előállítására | |
| ATE178044T1 (de) | Inhibitoren des arginin-ketoamid-enzyms | |
| HRP20050663A2 (en) | Malonamide derivatives as gamma-secretase inhibitors | |
| HUP0303538A2 (hu) | Tirozin kinázok Tec családjának tiazolil-vegyület inhibitorai és ezeket tartalmazó gyógyszerkészítmények | |
| DE60315674D1 (de) | Neue imidazopyridine und ihre verwendung | |
| CY1110969T1 (el) | 5-υποκατεστημενα-2-φαινυλαμινο-βενζαμιδια ως αναστολεiς μεκ | |
| TNSN07050A1 (fr) | Derives de triazolopyridinylsulfanyle servant d'inhibiteurs de kinase map p38 | |
| BR0314392A (pt) | Composto ou um sal do mesmo, composição farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de uma doença inflamatória e/ou alérgica ou deficiência cognitiva em um mamìfero, e, combinação | |
| NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
| RU2011124150A (ru) | Нафтилуксусные кислоты | |
| EA200802173A1 (ru) | Производные терфенила для лечения болезни альцгеймера | |
| BR0011097A (pt) | Derivados de 5-fenil-piridina | |
| HUP0301272A2 (hu) | 4-Fenil-piridin-származékok, mint neurokinin-1-receptor antagonisták, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására | |
| PE20070120A1 (es) | Derivados de prostaglandina | |
| RU2006126718A (ru) | Миметики гликозаминогликанов (gag) | |
| HUP0303005A2 (hu) | Pirazolo[4,3-d]pirimidineket vagy tienopirimidineket és endotelin receptor antagonistákat tartalmazó gyógyszerkészítmények | |
| HUP0303289A2 (hu) | Tienopirimidineket és trombózisellenes szereket, kalcium antagonistákat, prosztaglandinokat vagy prosztaglandinszármazékokat tartalmazó gyógyszerkészítmények | |
| MXPA05009788A (es) | Derivados del acido 3-(1-[3- (1, 3-benzotiazol -6-il)propilcarbomil] cicloalquil) propanoico como inhibidores de endopeptidasa neutra. | |
| DK1557414T3 (da) | IsoquinoIin-forbindelser og medicinsk anvendelse deraf | |
| HUP0401368A2 (hu) | Tienopirimidineket és trombózisellenes szereket, kalcium antagonistákat, prosztaglandinokat vagy prosztaglandin származékokat tartalmazó gyógyszerkészítmények | |
| BR0214488A (pt) | Derivados de benzotiazol | |
| HUP0302645A2 (hu) | Pirazolo[4,3-d]pirimidin-származékok alkalmazása gyógyszerkészítmények előállítására | |
| HUP0202614A2 (hu) | Tienopirimidin-vegyületek alkalmazása |